Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (97)	10/9/1999 11:08:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 362

Thanks, Harry. Sorry for the confusion, Marty. I feel better about NIH now (eliminates my "Sertoli" embarrassment). My comments stand, as they were focused on the size of the award and the necessity to transition to clinicals for the big bucks. I've administered phase I SBIR grants, and they're a pain in the rear. If you apply for phase II funding and don't get it, you've used a ton of resources for a modest amount of funding. If it's something you feel compelled to do in any event, it's nice to have the cash, even if it's a small amount. It's also good to have taken the first step to bigger bucks. Harry..... microcarriers? The cells won't scale-up without a scaffold, or is there some "in vivo" logic? Thanks again, Rick